0RGT.LSE Demant A/S
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2023.
Is 0RGT.LSE undervalued?
Graham numberThe Graham number of Demant A/S cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Demant A/S fundamental analysis
No fundamental analysis for Demant A/S yet.
Demant A/S stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founde…
Full company profileDemant A/S financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Demant A/S annual financial statements (DKK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 12.0B | 13.2B | 13.9B | 14.9B | 14.5B | - | - | - |
| Gross Profit | 9.03B | 10.1B | 10.8B | 11.3B | 10.3B | - | - | - |
| Operating Income | 1.94B | 2.34B | 2.53B | 2.15B | 1.53B | - | - | - |
| Net Income | 1.46B | 1.75B | 1.82B | 1.46B | 1.12B | - | - | - |
| Balance Sheet | ||||||||
| Total Assets | 15.5B | 16.2B | 17.9B | 21.8B | 21.9B | - | - | - |
| Total Liabilities | 8.59B | 8.80B | 10.9B | 14.2B | 13.7B | - | - | - |
| Shareholders' Equity | 6.96B | 7.43B | 7.05B | 7.64B | 8.25B | - | - | - |
| Cash & Short-term Investments | 710M | 697M | 630M | 792M | 952M | - | - | - |
| Total Debt | 1.96B | 2.31B | 2.16B | 4.06B | 4.94B | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 1.68B | 1.87B | 1.68B | 2.15B | 2.62B | 3.28B | 2.37B | - |
| Capital Expenditure | 319M | 312M | 429M | 571M | 507M | 562M | 647M | - |
| Ratios | ||||||||
| ROE | 21.0% | 23.6% | 25.9% | 19.1% | 13.6% | - | - | - |
| ROA | 9.4% | 10.8% | 10.2% | 6.7% | 5.1% | - | - | - |
| Net Profit Margin | 12.2% | 13.3% | 13.1% | 9.8% | 7.7% | - | - | - |
| Debt to Equity | 0.28x | 0.31x | 0.31x | 0.53x | 0.60x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Demant A/S dividends
Demant A/S has not paid dividends in the last 9 fiscal years.
Last stock split: 5:1 on May 25, 2016.
Who owns Demant A/S
- Insiders 60.00%
- Institutions 18.53%
- Public & others 21.47%
- Free float 83.8M
Demant A/S company profile
- Company name
- Demant A/S
- Ticker
- 0RGT.LSE
- ISIN
- DK0060738599
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 26,616
- Fiscal year end
- December
- Address
- Kongebakken 9, Smørum, Denmark, 2765
- Phone
- 45 39 17 73 00
- Website
- demant.com
About Demant A/S
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Demant A/S management
10- Mr. Søren NielsenCEO, President & Member of Executive Board · born 1970
- Mr. René Schneider M.ScCFO, President of Group Services & Member of Executive Board · born 1973
- Mr. Niels WagnerPresident of Hearing Care & Member of Executive Board · born 1971
- Sara Munch AndersenHead of Group Privacy & Compliance
- Stine BrandenhofGroup General Counsel
- Ms. Trine Kromann-MikkelsenVice President of Corporate Communication and Sustainability
- Mr. Peter PudselykkeHead of Investor Relations (Leave of Absence)
- Ms. Anne-Karen HuntPresident of Diagnostics Business Area · born 1977
- Mr. Bassel RifaiPresident of Hearing Aids Business Area · born 1982
- Gustav Kallehave HoeghInvestor Relations Officer